Legal & General Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.73M | Buy |
|
|||||
|
2025
Q2 | $1.59M | Buy |
|
|||||
|
2025
Q1 | $1.31M | Sell |
|
|||||
|
2024
Q4 | $1.71M | Buy |
|
|||||
|
2024
Q3 | $1.22M | Buy |
|
|||||
|
2024
Q2 | $1.36M | Buy |
|
|||||
|
2024
Q1 | $1.51M | Buy |
|
|||||
|
2023
Q4 | $1.28M | Buy |
|
|||||
|
2023
Q3 | $903K | Buy |
|
|||||
|
2023
Q2 | $834K | Buy |
|
|||||
|
2023
Q1 | $671K | Buy |
|
|||||
|
2022
Q4 | $725K | Buy |
|
|||||
|
2022
Q3 | $952K | Sell |
|
|||||
|
2022
Q2 | $914K | Buy |
|
|||||
|
2022
Q1 | $463K | Buy |
|
|||||
|
2021
Q4 | $355K | Buy |
|
|||||
|
2021
Q3 | $62K | Buy |
|
|||||
|
2021
Q2 | $75K | Buy |
|